iOS
Android
Facebook
WhatsApp
Twitter
CATAFLAM® (diclofenac potassium immediate-release tablets) is a benzene-acetic acid derivative. It is used to relieve pain and swelling (inflammation) from various mild to moderate painful conditions. It is also used to treat muscle aches, backaches, dental pain, menstrual cramps, and sports injuries. Reducing these symptoms helps you do more of your normal daily activities. CATAFLAM is available as immediate-release tablets of 50 mg (lightbrown) for oral administration.
Dosage and administration: Dose to be individually adjusted, Adverse effects may be minimised by using the lowest effective dose for the shortest duration necessary. Adults: The initial daily dose is 100 to 150 mg. In milder cases, 75 to 100 mg daily is usually sufficient.The total daily dose should generally be divided in 2 to 3 doses. Children and adolescents: Cataflam oral drops are particularly suitable for paediatric use, because they enable the dose to be adapted individually to the child's body weight in accordance with the dosage schedule recommended for children (1 drop = 0.5 mg). Children aged 1 year or over and adolescents should be given 0.5 to 2 mg/kg body weight (1 to 4 drops) daily, depending on the severity of the disorder. For adolescents aged 14 or over, 75 to 100 mg daily is usually sufficient. The total daily dose should generally be divided in 2 to 3 doses.Total maximum daily dose of 150 mg.
Active gastric or intestinal ulcer, bleeding or perforation; known hypersensitivity to diclofenac or to any of the excipients, to acetyl salicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs); last trimester of pregnancy; hepatic failure; renal failure (GFR <15 mL/min/1.73 m2); severe cardiac failure; known hypersensitivity to acetyl salicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs). Warnings and precautions: Caution recommended in patients with symptoms/history of gastrointestinal (GI) disease and in elderly because of the risks of GI bleeding or perforation. To be discontinued if these conditions occur. Combined use with protective agents to be considered in patients with history of ulcer, elderly and those requiring low dose acetyl salicylic acid. Caution when used concomitantly with corticosteroids, anticoagulants, anti-platelet agents or SSRIs. Caution recommended in patients with ulcerative colitis or Crohn’s disease.Treatment generally not recommended in patients with established heart disease(congestive heart failure, established ischemic heart disease, peripheral arterial disease)or uncontrolled hypertension or significant cardiovascular risk factors(e.g. hypertension, hyperlipidemia, diabetes mellitus and smoking), treat only after careful consideration and whit dose adjustment and periodic re-evaluation, especially when treatment continues for more than 4 weeks. Monitoring of blood counts recommended during prolonged treatment. Monitoring recommended in patients with defectsof haemostasis. Caution recommended in patients with asthma, seasonal allergic rhinitis or chronic pulmonary diseases. Risks of serious allergic reactions; To be discontinued if these conditions occur. Caution recommended in patients with impaired hepatic function (including porphyria). Monitoring of liver function during prolonged treatment. The information provided is for educational aid only. It is not indicated as medical advice or treatment. Please consult your physician for safety and effectiveness.
KES 5,800.00
Delivery within 4 hours on all orders placed between 8:00 AM & 8:00 PM
